Le réseau scientifique

Les collaborations internationales

Equipe Laurent ABEL

  • Bruce Beutler, Department of Immunology, The Scripps Research Institute, La Jolla, USA (prédisposition génétique pyogènes)
  • Helen Chapel, University of Oxford and Oxford Radcliffe Hospital, Oxford, UK (prédisposition génétique pyogènes)
  • David Cooper, Institute of Medical Genetics, University of Wales College of Medicine, Cardiff, UK (prédisposition génétique mycobactéries, candidose)
  • Bodo Grimbacher, University College London, Londres, UK (prédisposition génétique candidose)
  • Steven Holland, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, USA ((prédisposition génétique mycobactéries, pyogènes)
  • Dinakantha Kumararatne, Department of Clinical Immunology, Cambridge, UK (prédisposition génétique mycobactéries, pyogènes)
  • Xiaoxia Li, Cleveland Clinic Foundation, USA (pyogènes)
  • Desa Lilic, University of Newcastle, Newcastle, UK (prédisposition génétique candidose)
  • Anne O'Garra, National Institute for Medical Research, Londres, UK (prédisposition génétique tuberculose)
  • Peter Newburger, Departments of Pediatrics and Cancer Biology, University of Massachusetts Medical School Worcester USA (prédisposition génétique mycobactéries)
  • Jennifer Puck, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA (prédisposition génétique mycobactéries)
  • Charles Rice, Rockefeller University, New-York, USA (prédisposition génétique VHC)
  • Robert Schreiber, Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, USA (prédisposition génétique mycobactéries)

Equipe Corinne ANTIGNAC

  • Thomas Benzing, University of Cologne, Germany
  • Alessandra Boletta, Dulbecco Telethon Institute (DTI), Milan, Italie
  • Lewis Cantley, Division of Signal Transduction, Harvard Medical School, Beth Israel Deaconness Center, Boston, MA, USA.
  • Richard Cerione, Department of Molecular Medicine, Cornell University, Ithaca, NY, USA
  • Stéphanie Cherqui, Scripps Institute, La Jolla, USA
  • Erik Christensen, Arrhus, Dannemark
  • Pierre Courtoy, UCL, Bruxelles, Belgique
  • Olivier Devuyst, UCL, Bruxelles, Belgique
  • Iain Drummond, Massachusetts General Hospital, Charlestown, USA
  • Brian Harfe, University of Florida, Gainesville, USA
  • Friedlhem Hildebrandt, University of Michigan, Ann Arbor, USA
  • Lawrence Holzman, University of Michigan, Ann Arbor, USA
  • Anil Karihaloo, Yale University, New Haven, CO, USA
  • Jeffrey Kopp, NIDDK, Bethesda, USA
  • Michael McManus, University of California, San Francisco, USA
  • Jeffrey Miner, Washington University, Saint Louis, USA
  • Marcus Moeller, RWTH, Heidelberg, Germany
  • Peter Mundel, University of Miami, Miami, USA
  • Ulrich Rüther, Institut für Entwicklungs- und Molekularbiologie der Tiere (EMT), Düsseldorf, Germany
  • Franz Schaefer, Heidelberg, Germany

Equipe Alain Fischer

  • F.D. Bushamann, Philadelphie, U.S.A. Etude des sites d’intégration de vecteurs de thérapie génique
  • F. Candotti, NIH (génétique) Bethesda, U.S.A. Modèles animaux déficit immunitaire
  • R. Casella, NCI, Bethesda, U.S.A. Etude du système immunitaire
  • H. Chapel, Oxford, U.K. Activation des cellules du système immunitaire. Déficit immunitaire
  • M. Nussenzweig (Rockfeller University New-York, U.S.A.) Etude du système immunitaire (lymphocytes B)
  • A. Trasher (University College London, Institute of Child Health) Therapie génique SCID et Wilott Aldrech
  • A.Veillette, ICRM Montréal, Canada
  • D. Williams (Harvard Boston) – SCID Centre production vecteurs à Cincenatti

Equipe Stanislas Lyonnet

  • ERANET CraniRare : Pr B Wollnik (Koeln Univ., Germany), Dr N Akarsu (Hacettepe Univ., Ankara, Turquie), Dr U Kayserili (Istanbul, Turquie), Dr D Wieczorek (Essen Univ., Germany)
  • ERANET Hirschsprung disease Consortium : Dr I Ceccherini (Genoa, Itaky) ; Dr S Borrego (Barcelona, Spain)
  • European Skeletal Dysplasia Network et Eurogrow (7 partenaires européens)
  • International Hirschsprung Disease Consortium: A Chakravarti (Johns Hopkins, Baltimore, USA); C Eng (OSU, Ohio, USA) ; R Hofstra (Groningen, The Netherlands) ; I Ceccherini (Genoa, Italie) ; S Borrego (Barcelone, Espagne) ; P Tam (Hong-Kong, RPC)
  • International Network on Ciliopathies: H Dollfus (IGBMC Starsbourg), C Antignac and S Saunier (INSERM U-574, Necker), EM Valente (CSS Mendel, Roma, Italy), J Gleeson (Howard Hughes, UCSD, USA), N Katsanis (Johns Hopkins Baltimore)
  • Laboratoire International Associé (LIA) Franco-Marocain de l’INSERM : Pr A Sefiani (INH and Rabat Univ., Morocco)
  • NIH Project N°5PO1 HD39948 : Hereditary basis of Neural Tube Defects. MC Speer (PI, Duke Univ., USA), M Lovett (Washington Univ., USA)

Equipe Valérie Cormier-Daire

  • Yasemin Alanay, Hacettepe Unviersity, Ankara, Turquie
  • Skeletal Dysplasia Registry, Cedars Sinai Medical Center, (Head : David Rimoin), Los Angeles, USA
  • Stephen Robertson, Université d’Otago, Dunedin, Nouvelle Zélande
  • S.S. Apte, Lerner Research Institute, Cleveland, USA
  • André Mégarbane, Université St Joseph, Beyrouth, Liban
  • Z.Q. Pan, Department of Oncological Sciences, Mount Sinai School of Medicine, Los Angeles, USA
  • Annick Raas Rothschild, Hadassah Hebrew University, Jérusalem, Israël

Equipe Asma Smahi

  • Dr Gnamey : Anhydrotic ectodermal dysplasia, Togo
  • Manolis Pasparakis, Mouse models of NFkB pathologies, University of Cologne, Germany
  • Aleria Ursini, Genetic and molecular analysis of IP, Institute of Genetics and Biophysics, Naples, Italy
  • Dr Amal Said, Psoriasis, Marrakech Hospital, Morocco
  • Dr Hamida Turki and Dr Slaheddine Marrakchi, Psoriasis, Sfax Hospital, Tunisia
  • Shoji Yamaoka, Genetic and molecular analysis of NF-kB signaling, Department of Molecular Virology, Tokyo Medical and Dental University, Japan

Equipe Laurence Colleaux

  • Nigel Carter : Sanger Institute, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
  • Malika Chaouch, Hopital Ben Acknoun, Alger, Algérie
  • Josef Gecz, Department of Genetic Medicine, Women's and Children's Hospital, North Adelaide, Australia
  • Annick Raas-Rotschild, Department of Human Genetics, HADASSAH University Hospital, Jerusalem, Israel
  • Orit Reish, Department of Medical Genetics, Assaf Harofeh, Israel
  • Patrick Tarpey : Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK

Equipe Jean-Michel Rozet

  • Rando Allikmets, Department of Ophthalmology, Columbia University, New-York, USA
  • Shomi Bhattacharya, Institute of Ophthalmology, UCL, London, UK
  • Johanna Seddon, Massachusetts Eye and Ear Infirmary, Boston, USA
  • Enza Maria Valente, Neurogenetics Unit, CSS-Mendel Institute, Roma, Italy

Equipe Geneviève Gourdon

  • Darren Monckton, Glasgow, UK
  • Glenn Morris, Anticorps Msh3, UK
  • Giuseppe Novelli, Annalisa Bota, Preclinical study of gene therapy, Italy
  • Christopher Pearson, Study of the implication of replication in the instabily of repeated CGT triplets, Toronto, Canada
  • Jack Puymirat, Therapeutic trials with antisense vectors, ribozyme and RNAi, Quebec, Canada
  • Laura Ranum, Study of protein aggregates in the nervous system of transgenic mice, USA 
  • Hein te Riele, Amsterdam, NL
  • Maurice Swanson, Preclinical study of gene therapy, USA
  • Ibtissam Walker, Studies of nerves anomaly of transgenic mice, Lausanne, CH
  • Bé Wieringa, Nimjegen, NL

Equipe Agnès Rötig

  • Orly Elpeleg, Hadassah Hospital, Jérusalem, Israël
  • ERANET CraniRare : Pr B Wollnik (Koeln Univ., Germany), Dr N Akarsu (Hacettepe Univ., Ankara, Turquie), Dr U Kayserili (Istanbul, Turquie), Dr D Wieczorek (Essen Univ., Germany)
  • ERANET Hirschsprung disease Consortium : Dr I Ceccherini (Genoa, Itaky) ; Dr S. Borrego (Barcelona, Spain)

Equipe Olivier Danos

  • Robin Ali, Department of Ophtalmology, UCL, London
  • Andrea Ballabio, Telethon Institute of Genetics and Medicine, Naples, Italy
  • Mary Collins, Division of Infection and Immunity, University College London, London, UK
  • Ronald Crystal, Cornell University, New York, USA
  • Kay Davies, Department of Physiology Anatomy and Genetics, Oxford University, Oxford UK
  • John Hopwood, Department of Chemical Pathology, Women and Children Hospital, North Adelaide, Australie
  • Robert Kotin, National Heart Blood and Lung Institute, Bethesda, USA
  • David Linch, Hematology, UCL Cancer Institute, UCL, London
  • Richard Mulligan, Harvard Medical School, Boston, USA
  • Francesco Muntoni, Dubowitz Neuromuscular Centre, UCL Institute of Child Health, London, UK
  • Amit Nathwani, Hematology, UCL Cancer Institute, University College London, London, UK
  • Adrian Thrasher, UCL Institute of Child Health, London, UK

Equipe Martine Le Merrer

  • Pr Cassiman, Eurogentest, Belgium
  • Giovanni Romeo, R.Stevens, Eurogene